Urticaria
An Introduction to Urticaria
Stay up to date with the latest clinical breakthroughs and highlights from major global conferences through expert-led conference coverage, concise insights and news articles. Browse premium, actionable practice pearl articles designed to support continuous development, confidence and clinical decision-making. Plus, explore free-to-view, peer-reviewed articles from our leading international journal, alongside high-quality educational activities—with patient outcomes at the forefront.
Dermatologists now have a new tool to transform the treatment landscape for patients living with chronic spontaneous urticaria (CSU): the first and only oral Bruton’s tyrosine kinase inhibitor (BTKi) approved by the FDA for this condition. This oral therapy is indicated for adults with CSU who remain symptomatic despite treatment with H1 antihistamines. Taken twice daily, it requires no injections or routine laboratory monitoring, offering a convenient and targeted option for patients whose symptoms persist on standard care.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career doctors ready to think beyond the bedside and explore the business of medicine.
In this episode, we explore the future of continuing medical education (CME) with the team behind touchIME. Hannah Fisher and Matthew Goodwin share insights into global and US trends, the importance of patient inclusivity and how educational outcomes are evolving to better measure the direct impact of learning on clinical practice and patient care.
A globally recognized allergologist specializing in urticaria, drug allergies, and angioedema, Professor Luis FC Ensina has significantly advanced clinical care, research, and education. As a Professor at the Federal University of São Paulo and coordinator of its specialized outpatient clinic, he leads Alergoalpha, a Center of Excellence for UCARE, ACARE, and ADCARE, where he has overseen over 20 clinical trials and authored more than 100 publications. A founder of the Brazilian Urticaria Network (RUBRA) and co-author of international urticaria guidelines, he has played a pivotal role in shaping global standards for allergy care. Active in organizations such as GA2LEN, AAAAI, and EAACI, he highlights the transformative potential of emerging therapies, gene therapy, and artificial intelligence to redefine allergy and immunology practice worldwide.
We are deeply saddened to learn that Prof. Marcus Maurer, a highly esteemed expert and valued member of the touchIMMUNOLOGY faculty, has been missing for several weeks following a hiking expedition in the mountains.
Urticarial vasculitis is a rare inflammation of the blood vessels which results in clinical manifestations resembling urticaria with the addition of wheals, there remain no direct treatment options and management involves antihistamines, NSAIDS and ibuprofen to treat the cutaneous manifestations. ...
The CRUSE® app has been developed for the self-management of chronic spontaneous urticaria (CSU), and to help physicians develop personalised treatment strategies for patients. touchIMMUNOLOGY were delighted to speak with Prof. Marcus Maurer (Professor of Dermatology and Allergy, Charité – Universitä...
Phase 2 results of remibrutinib for chronic spontaneous urticaria (CSU) show a fast and sustained response to treatment. While the phase 3b trial is ongoing, touchIMMUNOLOGY were delighted to speak with Prof. Marcus Maurer (Professor of Dermatology and Allergy, Charité – Universitä...
Log into your Touch Account
Keep track of your clinical interests and newsletter subscriptions.
Sign up with an Email
Or use a .
Register now for FREE access
Already registered? Login below.
